Expression of family A melanoma antigen in human gastric carcinoma

Anticancer Research

Volumn 25, Issue 3 B, 2005, Pages 2105-2111

  Jung, Eun Ji ^a   Kim, Min A ^a   Lee, Hye Seung ^a   Yang, Han Kwang ^a   Lee, You Mie ^a   Lee, Byung Lan ^a   Kim, Woo Ho ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

DNA methylation; Immunohistochemistry; Reverse transcriptase polymerase chain reaction; Stomach neoplasms; Survival analysis; Tumor antigen

Indexed keywords

MELANOMA ANTIGEN; MELANOMA ANTIGEN 1; MELANOMA ANTIGEN 2; MELANOMA ANTIGEN 3; UNCLASSIFIED DRUG;

ADVANCED CANCER; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CANCER IMMUNOTHERAPY; CANCER INVASION; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA METHYLATION; DRUG TARGETING; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MULTIGENE FAMILY; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CARCINOMA; WESTERN BLOTTING;

ANTIGENS, NEOPLASM; CELL LINE, TUMOR; DNA METHYLATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; STOMACH NEOPLASMS;

EID: 21344467916     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Chomez P, De Backer O, Bertrand M, De Plaen E, Boon T and Lucas S: An overview of the MAGE gene family with the identification of all human members of the family. Cancer Res 61: 5544-5551, 2001.
2. De Plaen E, Arden K, Traversari C, Gaforio JJ, Szikora JP, De Smet C, Brasseur F, van der Bruggen P, Lethe B and Lurquin C: Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics 40: 360-369, 1994.
3. Barker PA and Salehi A: The MAGE proteins: emerging roles in cell cycle progression, apoptosis, and neurogenetic disease. J Neurosci Res 67: 705-712, 2002.
4. Jones PA and Takai D: The role of DNA methylation in mammalian epigenetics. Science 293: 1068-1070, 2001.
5. Narayan A, Ji W, Zhang XY, Marrogi A, Graff JR, Baylin SB and Ehrlich M: Hypomethylation of pericentromeric DNA in breast adenocarcinomas. Int J Cancer 77: 833-838, 1998.
6. Rimoldi D, Romero P and Carrel S: The human melanoma antigen-encoding gene, MAGE-1, is expressed by other tumour cells of neuroectodermal origin such as glioblastomas and neuroblastomas. Int J Cancer 54: 527-528, 1993.
7. Van Pel A, van der Bruggen P, Coulie PG, Brichard VG, Lethe B, van den Eynde B, Uyttenhove C, Renauld JC and Boon T: Genes coding for tumor antigens recognized by cytolytic T lymphocytes. Immunol Rev 145: 229-250, 1995.
8. Brasseur F, Marchand M, Vanwijck R, Herin M, Lethe B, Chomez P and Boon T: Human gene MAGE-1, which codes for a tumor-rejection antigen, is expressed by some breast tumors. Int J Cancer 52: 839-841, 1992.
9. Yoshimatsu T, Yoshino I, Ohgami A, Takenoyama M, Hanagiri T, Nomoto K and Yasumoto K: Expression of the melanoma antigen-encoding gene in human lung cancer. J Surg Oncol 67: 126-129, 1998.
10. Inoue H, Mori M, Li J, Mimori K, Honda M, Nakashima H, Mafune K, Tanaka Y and Akiyoshi T: Human esophageal carcinomas frequently express the tumor-rejection antigens of MAGE genes. Int J Cancer 63: 523-526, 1995.
11. Sigalotti L, Coral S, Nardi G, Spessotto A, Cortini E, Cattarossi I, Colizzi F, Altomonte M and Maio M: Promoter methylation controls the expression of MAGE2, 3 and 4 genes in human cutaneous melanoma. J Immunother 25: 16-26, 2002.
12. Suyama T, Ohashi H, Nagai H, Hatano S, Asano H, Murate T, Saito H and Kinoshita T: The MAGE-Al gene expression is not determined solely by methylation status of the promoter region in hematological malignancies. Leuk Res 26: 1113-1118, 2002.
13. Choi JH, Kwon HJ, Yoon BI, Kim JH, Han SU, Joo HJ and Kim DY: Expression profile of histone deacetylase 1 in gastric cancer tissues. Jpn J Cancer Res 92: 1300-1304, 2001.
14. Honda T, Tamura G, Waki T, Kawata S, Terashima M, Nishizuka S and Motoyama T: Demethylation of MAGE promoters during gastric cancer progression. Br J Cancer 90: 838-843, 2004.
15. Kim MS, Kwon HJ, Lee YM, Back JH, Jang JE, Lee SW, Moon EJ, Kim HS, Lee SK, Chung HY, Kim CW and Kim KW: Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat Med 7: 437-443, 2001.
16. Cravo M, Pinto R, Fidalgo P, Chaves P, Gloria L, Nobre-Leitao C and Costa Mira F: Global DNA hypomethylation occurs in the early stages of intestinal type gastric carcinoma. Gut 39: 434-438, 1996.
17. Jang SJ, Soria JC, Wang L, Hassan KA, Morice RC, Walsh GL, Hong WK and Mao L: Activation of melanoma antigen tumor antigens occurs early in lung carcinogenesis. Cancer Res 61: 7959-7963, 2001.
18. Lee HS, Lee HK, Kim HS, Yang HK, Kim YI and Kim WH: MUC1, MUC2, MUC5AC, and MUC6 expressions in gastric carcinomas: their roles as prognostic indicators. Cancer 92: 1427-1434, 2001.